Immunology and immunopathology - Molecular and cellular pathology Single channel
Chair (Coordinator) and Rapporteur: CRISTINA CERBONI
Module 1: Immunology and immunopathology - Molecular and cellular pathology I
- Activity type
- Discipline biotecnologiche comuni, Discipline fondamentali applicate alle biotecnologie
- SSD
- MED/04, MED/04
- Year
- N/D
- Semester
- N/D
- CFU
- 4
- Hours distribution
- 32 classroom hours
- Lecturers
- CRISTINA CERBONI
GIOVANNI BERNARDINI
Module 2: Immunology and immunopathology - Molecular and cellular pathology II
- Activity type
- Discipline biotecnologiche comuni
- SSD
- MED/04
- Year
- N/D
- Semester
- N/D
- CFU
- 3
- Hours distribution
- 24 classroom hours
- Lecturers
- ZEIN MERSINI BESHARAT
ELISABETTA FERRETTI
Module 3: Immunology and immunopathology - Molecular and cellular pathology III
- Activity type
- Medicina di laboratorio e diagnostica
- SSD
- MED/46
- Year
- N/D
- Semester
- N/D
- CFU
- 3
- Hours distribution
- 24 classroom hours
- Lecturers
- MARIA HELENA STABILE
GIOVANNI BERNARDINI
Module 4: Immunology and immunopathology - Molecular and cellular pathology IV
- Activity type
- Attività formative affini o integrative
- SSD
- MED/46
- Year
- N/D
- Semester
- N/D
- CFU
- 2
- Hours distribution
- 16 classroom hours
- Lecturers
- AGNESE PO
Objectives
General objectives:
The main objective of the teaching is to provide the student with more knowledge in the fields of immunology and diseases associated with the immune system, as well as with general pathology. The deepening of the cellular and molecular processes underlying different diseases, and of the new diagnosis and therapeutic tools offered by biotechnologies, will offer the student an up-to-date view on the different possibilities of diagnosis and therapy.
Lectures will help to develop competences on the etiopathogenic bases of diseases, fundamental for a biotechnological medical approach to themselves.
Specific objectives:
The Immunology and Immunopathology part of the course is aimed at providing the students with the basic knowledge on the molecular mechanisms underlying the main immune-mediated disorders in humans, and how they can be exploited for innovative biotechnology-based diagnostic and therapeutic interventions.
Particular attention will be given to the study of chronic inflammatory diseases, response to infections, allergic reactions, rejection of organ and tissue transplants, immunotherapies of tumors and primary immunodeficiencies.
The part of the course related to Molecular and Cellular Pathology aims to provide the basic knowledge to make the student able to understand the molecular and cellular mechanisms that regulate pathological processes in humans. In recent years, important discoveries have highlighted the importance of the study of pathologies both at the cellular and molecular level. The knowledge of the molecular processes that underlie diseases allows the development of new biological therapies, demonstrating how fundamental the analysis of the molecular and cellular aspect is, generating new questions and opening up to further analysis. The knowledge of the pathogenetic mechanisms of human diseases, at the molecular and cellular level, allows to create the necessary substrate for a biotechnological approach in different fields, such as prevention, diagnosis, treatment, and clinical aspects of human diseases. In particular, the focus will be on the molecular and cellular bases of those human diseases whose incidence has increased in recent years, in relation to the fact that the average age of the human population has grown. Therefore, diseases such as malignancies and chronic degenerative diseases – e.g., diabetes and atherosclerosis - will be discussed. The pathogenetic mechanisms of non-coding RNA (microRNA and long non-coding RNA) will be also examined. Molecular mechanisms regulating the maintenance of stem cells, their use for therapeutic purposes and the involvement of cancer stem cells in the maintenance of tumor processes will be described. The methods of next generation sequencing (NGS) and some practical examples will be discussed as well.
For both modules, among the specific objectives that the student will achieve at the end of the course, there will be:
- the ability to perform bibliographic searches in international scientific databases (eg PubMed);
- the ability to select scientific articles on the topics covered during the course;
- the ability to understand and elaborate a scientific article in English;
- the integration of the knowledge acquired during the course with the international scientific literature;
- the ability to communicate orally, through a computer presentation (with the power point program), the results described in a scientific article;
- the ability to study autonomously, self-administered and integrating material from multiple sources (textbooks, material provided by teachers, scientific literature).
The ability to search scientific data and literature on specific subjects, the ability to assess the impact that the various scientific journals have in the international community, together with the knowledge and skills in the field of immunology and pathology, will provide the student with useful and crucial tools for consulting multiple sources, developing research projects, analyzing data, communicating results, and gaining more knowledge on some of the latest biotechnological innovations applied in the biomedical field.
Learning outcomes
The main objective of the teaching is to provide the student with more knowledge in the fields of immunology and diseases associated with the immune system, as well as with general pathology. The deepening of the cellular and molecular processes underlying different diseases, and of the new diagnosis and therapeutic tools offered by biotechnologies, will offer the student an up-to-date view on the different possibilities of diagnosis and therapy.
Lectures will help to develop competences on the etiopathogenic bases of diseases, fundamental for a biotechnological medical approach to themselves.
The Immunology and Immunopathology part of the course is aimed at providing the students with the basic knowledge on the molecular mechanisms underlying the main immune-mediated disorders in humans, and how they can be exploited for innovative biotechnology-based diagnostic and therapeutic interventions.
Particular attention will be given to the study of chronic inflammatory diseases, response to infections, allergic reactions, rejection of organ and tissue transplants, immunotherapies of tumors and primary immunodeficiencies.
The part of the course related to Molecular and Cellular Pathology aims to provide the basic knowledge to make the student able to understand the molecular and cellular mechanisms that regulate pathological processes in humans. The knowledge of the pathogenetic mechanisms of human diseases, at the molecular and cellular level, allows to create the necessary substrate for a biotechnological approach in different fields, such as prevention, diagnosis, treatment, and clinical aspects of human diseases. In particular, the focus will be on the molecular and cellular bases of those human diseases whose incidence has increased in recent years, in relation to the fact that the average age of the human population has grown. Therefore, diseases such as malignancies and chronic degenerative diseases – e.g., diabetes and atherosclerosis - will be discussed. The pathogenetic mechanisms of non-coding RNA (microRNA and long non-coding RNA) will be also examined. Molecular mechanisms regulating the maintenance of stem cells, their use for therapeutic purposes and the involvement of cancer stem cells in the maintenance of tumor processes will be described. The methods of next generation sequencing (NGS) and some practical examples will be discussed as well.
For both modules, among the specific objectives that the student will achieve at the end of the course, there will be:
- the ability to perform bibliographic searches in international scientific databases (eg PubMed);
- the ability to select scientific articles on the topics covered during the course;
- the ability to understand and elaborate a scientific article in English;
- the integration of the knowledge acquired during the course with the international scientific literature;
- the ability to communicate orally, through a computer presentation (with the power point program), the results described in a scientific article;
- the ability to study autonomously, self-administered and integrating material from multiple sources (textbooks, material provided by teachers, scientific literature).
The ability to search scientific data and literature on specific subjects, the ability to assess the impact that the various scientific journals have in the international community, together with the knowledge and skills in the field of immunology and pathology, will provide the student with useful and crucial tools for consulting multiple sources, developing research projects, analyzing data, communicating results, and gaining more knowledge on some of the latest biotechnological innovations applied in the biomedical field.
Prerequisites
The student will need to know the cellular and soluble components of the immune system, as well as their functioning within the immune response. In particular, the basic knowledge required at the beginning of the teaching are:
- General characteristics of immune responses.
- Cells and tissues of the immune system.
- Innate immunity: cells and soluble mediators.
- Adaptive immunity: CD4 + and CD8 + T lymphocytes, MHC and antigen presentation, cytokines.
- Receptors and signaling pathways of the immune system.
- Lymphocyte maturation and BCR/TCR rearrangement.
- Adaptive immunity: B lymphocytes, antibodies, cytokines.
- Effector mechanisms of humoral immunity.
Programme
Module: Immunology and immunopathology - Molecular and cellular pathology I
During the course, the topics will be the following:
- Inflammatory cytokines, chemokines and their receptors: etiopathogenetic role.
- Cells of innate immunity: NK and ILCs.
- Mucosal immunity.
- Immunity to bacterial and viral infections.
- Immunity and tumors: new biotechnological approaches in tumor immunotherapy.
- Prophylactic and therapeutic vaccines.
- Allergies.
- Congenital immunodeficiencies: gene and cell therapy approaches.
- Immunity and transplantation: new biotechnological approaches in the control of rejection reactions of organ and tissue transplants.
- Tolerance and autoimmunity.
Module: Immunology and immunopathology - Molecular and cellular pathology II
N/D
Module: Immunology and immunopathology - Molecular and cellular pathology III
N/D
Module: Immunology and immunopathology - Molecular and cellular pathology IV
The course will consist of lectures. The topics will be:
1) Getting started and general aspects of molecular and cellular pathology
- Concept and causes of alteration in the cell, cellular and tissue homeostasis
- Cellular damage: causes, molecular mechanisms, responses and adaptations
- Cell death and its manifestations: necrosis and apoptosis
- Aging Cell
- Cell growth and differentiation adaptations: hyperplasia, hypertrophy, atrophy, metaplasia: causes, forms and mechanisms. Dysplasia and carcinoma in situ. Stem Cells
- Disorders of the cytoskeleton: actin microfilaments, intermediate filaments, microtubules
- Storage diseases: fatty liver, amyloidosis, Alzheimer's disease, prion diseases
- Atherosclerosis
2) Molecular and cellular pathology of cancer
- Definition and classification of tumors
- Stages of tumor progression: initiation, promotion, progression, invasiveness and metastasis
- Dominant and recessive mutations: oncogenes and tumor suppressor
- Genetic predisposition to hereditary cancer: RB, p53, multigenic defects. Importance of epigenetic factors
- Features that must acquire a cell to become cancerous. Molecular pathways involved in different aspects of tumor development.
- Identification of tumor markers. Significance of tumor markers in the prevention and staging / classification of tumors
3) Relationship between molecular pathology and phenotype: definitions and genetic basis of multiple endocrine neoplasia as an example of complex disease with known molecular basis: classes of mutations report structure-function clinical
4) Stem cells: embryonic stem cells, adult stem cells. Therapeutic applications of stem cells. Cancer stem cells: biological features and epignetic regulation.
5) Pathogenetic mechanisms of non-coding RNAs: microRNAs and long non-coding RNAs.
microRNA: biogenesis, deregulation mechanisms in pathologies, circulating microRNAs; long non-coding RNA: biogenesis, mechanisms of action, examples of long non-coding deregulated in pathologies.
6) Next generation Sequencing (NGS) : introduction to NGS tecniques. Illumina platform, Ion Torrent. Applications: Genome Sequencing, Whole exome sequencing, Targeted sequencing. Analysis of NGS derived data:bioinformatics analysis, analysis of the transcriptome and of the mirnome.
Books
Module: Immunology and immunopathology - Molecular and cellular pathology I
Textbooks
K. Abbas, A. H. Lichtman, S. Pillai, Cellular and Molecular Immunology (9th Edition), Ed. Elsevier.
Pontieri, Russo, Frati: "General Pathology" Ed. Piccin
Robbins and Cotran: "The pathological basis of diseases" Ed. Elsevier.
Handouts and articles provided by the professors
Module: Immunology and immunopathology - Molecular and cellular pathology II
N/D
Module: Immunology and immunopathology - Molecular and cellular pathology III
N/D
Module: Immunology and immunopathology - Molecular and cellular pathology IV
study material provided during the course and available on a dedicated platform
Bibliography
Module: Immunology and immunopathology - Molecular and cellular pathology I
N/D
Module: Immunology and immunopathology - Molecular and cellular pathology II
N/D
Module: Immunology and immunopathology - Molecular and cellular pathology III
N/D
Module: Immunology and immunopathology - Molecular and cellular pathology IV
N/D
Lessons mode
The course will mainly consist of lectures, held by each professor. Attendance is mandatory.
Some lessons could be held by foreign professors, coming from prestigious research institutes and universities, on the basis of agreements made between the professors during the Academic Year. These lessons will be mandatory, as they will be held during the calendar of the course.
Students will be also invited to attend seminars on biomedicine topics, held by national and international speakers. In this case, attendance is not mandatory.
Frequency
Mandatory
Exam mode
Oral exam.
During the oral examination the student must demonstrate that he has acquired sufficient knowledge of all the topics addressed in class.
To achieve a final score equal to 30/30 cum laude, the student must prove that he has acquired an excellent knowledge of all the topics covered during the course, and has to achieve 30/30 cum laude in both modules.
For the purposes of the evaluation, the student's ability to reason and to explain the topics clearly and with the right terminology will be taken into account, demonstrating the ability to connect them in a logical and coherent way.
In the final evaluation of each module, the percentage of presences at the lectures will be taken into consideration.
It will be the student's choice to be evaluated for one or both modules in the same day, or in different days, according to the order he/she feels more appropriate to him/her. In the latter case, the professors will take note of the score obtained in the first module chosen.
The final score will be the result of the average of the two scores obtained in the two modules.
Example exam questions
Questions on the topics of the courses
Arguments
Module: Immunology and immunopathology - Molecular and cellular pathology I
- Inflammatory
cytokines, chemokines and their receptors: etiopathogenetic role. - Cells
of innate immunity: NK and ILCs. - Mucosal immunity.
- Immunity
to bacterial and viral infections. - Immunity
and tumors: new biotechnological approaches in tumor immunotherapy. - Prophylactic
and therapeutic vaccines. - Allergies
- Congenital
immunodeficiencies: gene and cell therapy approaches. - Immunity
and transplantation: new biotechnological approaches in the control of
rejection reactions of organ and tissue transplants. - Tolerance and autoimmunity.
Module: Immunology and immunopathology - Molecular and cellular pathology II
N/D
Module: Immunology and immunopathology - Molecular and cellular pathology III
N/D
Module: Immunology and immunopathology - Molecular and cellular pathology IV
Sustainability goals
- Academic year2026/2027
- Degree program to which the course belongsMedical Biotechnology
- LanguageITA
- CFU12 CFU, distributed among 4 integrated didactic modules
- Total duration96 hours